Structure-Based Discovery of Imidazo[4,5- c ]pyridine SARM1 Modulators Showing Paradoxical Activation
Journal of Medicinal Chemistry · 23.04.2026 · 69 (8) · 9521-9536
DOI: 10.1021/acs.jmedchem.6c00352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 08.04.2026. Verfasst von Steven K Albanese und 25 weiteren Autor:innen. Beteiligte Einrichtung: Schrödinger, Inc., New York, New York 10036, United States. Hauptthemen laut MEDLINE: Armadillo Domain Proteins, Cytoskeletal Proteins, Drug Discovery, Pyridines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Sterile Alpha and TIR Motif Containing 1 (SARM1) is an NAD+ hydrolase enzyme implicated in neurological diseases with prominent axonopathies. A reported method for SARM1 inhibition involves the design of small molecules bearing reactive heterocyclic warheads, which intercept the hydrolysis of NAD+ in the active site of SARM1 and subsequently inhibit enzymatic function of the TIR domain. Herein, we describe the discovery of a series of bicyclic SARM1 inhibitors, initially identified via a unique workflow for free-energy perturbation (FEP+) simulations. Subsequent hit expansion efforts identified potent and cell-active inhibitors with slow off-rates, which impart a unique conformational state of W662 in the SARM1 catalytic site, as assessed via X-ray crystallography. Finally, we discuss an identified liability associated with substrate-based SARM1 inhibitors such as 19, whereby insufficient target engagement results in an increase in biomarkers of neurodegeneration at low doses in vivo and exacerbates neuronal degeneration and cell death in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Schrödinger, Inc., New York, New York 10036, United States.
- Schrödinger, Inc., Framingham, Massachusetts 01702, United States.
- Bristol Myers Squibb, East Cambridge, Massachusetts 02141, United States.
- Schrödinger, Inc., Hyderabad, Telangana 500032, India.
- Schrödinger, Inc., San Diego, California 92122, United States.
- Schrödinger, Inc., Cambridge, Massachusetts 02142, United States.
ORCID-Profile: Ward G Walkup, Pieter H Bos, Adam M Levinson
Zitieren
APA
Albanese, S. K., Hopkins, B. E., Olland, A. M., Fairman, A., Shaikh, N., Feng, S., Thakkar, M., Verras, A., Dementiev, A., Walkup, W. G., Atsriku, C., Srinivas, H. D., Allen, W., Ashraf, K., Bos, P. H., Hsiao, P., Kroeck, K., Liu, Z., Nagarajan, A., …, & Levinson, A. M. (2026). Structure-Based Discovery of Imidazo[4,5- c ]pyridine SARM1 Modulators Showing Paradoxical Activation. Journal of Medicinal Chemistry, 69(8), 9521-9536. https://doi.org/10.1021/acs.jmedchem.6c00352
Vancouver
Albanese SK, Hopkins BE, Olland AM, Fairman A, Shaikh N, Feng S, et al. Structure-Based Discovery of Imidazo[4,5- c ]pyridine SARM1 Modulators Showing Paradoxical Activation. Journal of Medicinal Chemistry. 2026;69(8):9521-9536. doi:10.1021/acs.jmedchem.6c00352
BibTeX
@article{Albanese2026,
author = {Albanese, Steven K and Hopkins, Brittany E and Olland, Andrea M and Fairman, Alexis and Shaikh, Nadim and Feng, Shulu and Thakkar, Mahesh and Verras, Andreas and Dementiev, Alexey and Walkup, Ward G and Atsriku, Christian and Srinivas, Harathi D and Allen, Wayne and Ashraf, Khuram and Bos, Pieter H and Hsiao, Peng and Kroeck, Kyle and Liu, Zhijian and Nagarajan, Anu and Szlenk, Christopher T and Svensson, Mats and Johnson, Zachary Lee and Kapilashrami, Kanishk and Rubino, Stephen and Kaplan, Andrew and Levinson, Adam M},
title = {Structure-Based Discovery of Imidazo[4,5- c ]pyridine SARM1 Modulators Showing Paradoxical Activation},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {8},
pages = {9521--9536},
doi = {10.1021/acs.jmedchem.6c00352}
}
EUVIMED